Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Anna Engell Holm (Copenhagen, Denmark), Anna Engell Holm, Hans Henrik Schutz, Michael Perch, Tacjana Pressler, Jørn Carlsen, Martin Iversen. Colonization of bacteria after lung transplantation in cystic fibrosis (CF) patients occurs early but does not impact survival. Eur Respir J 2015; 46: Suppl. 59, 1297

Member's Comments

No comment yet.

Related content which might interest you: Value of bronchoalveloar lavage (BAL) in management of lung infections in adult cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Ability of the lung clearance index to monitor progression of early lung disease in children with cystic fibrosis Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 BAL neutrophilia increases mortality in lung transplant patients despite azithromycin treatment Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction Year: 2013 Bacterial etiology of exacerbations of non-cystic fibrosis bronchiectases in young patients Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Early detection of lung disease in cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage Year: 2007 Characterization of inflammation in bronchoalveolar lavage of lung transplant patients Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Posaconazole levels in the bronchoalveolar lavage from lung transplant recipients Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Eosinophilia predicts poor outcome after lung transplantation Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction Year: 2013 Heterogeneity within chronic lung allograft dysfunction: A BAL analysis Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 A follow-up study with broncho-alveolar lavage (BAL) to assess the importance of airway colonization in lung transplantation (LTx) Source: Eur Respir J 2006; 28: Suppl. 50, 778s Year: 2006 Bacterial infection and lung function in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 615s Year: 2005 The impact of colonization with therapy-resistant pathogens on the survival rate after lung transplantation (LUTX) in cystic fibrosis (CF) Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung transplantation Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls Source: International Congress 2014 – ILDs 4 Year: 2014 Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis Source: Eur Respir J 2001; 17: 281-286 Year: 2001 Airway dendritic cell phenotypes in inflammatory diseases of the human lung Source: Eur Respir J 2007; 30: 878-886 Year: 2007 Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Cathelicidin (LL-37) ve human β2 defensin levels in bronchoalveolar fluid of pediatric patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Paediatric pulmonary infections Year: 2015